Ignite Creation Date:
2025-12-24 @ 10:30 PM
Ignite Modification Date:
2026-06-26 @ 4:05 AM
Study NCT ID:
NCT00505635
Status:
TERMINATED
Last Update Posted:
2020-09-24
First Post:
2007-07-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Biochemotherapy With Temozolomide for Metastatic Melanoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Melanoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | advanced stage IV melanoma | View |
| None | unresectable stage III melanoma | View |
| None | Melanoma | View |
| None | Temozolomide | View |
| None | Velban | View |
| None | Vinblastine | View |
| None | Cisplatin | View |
| None | Interleukin-2 | View |
| None | Intron-A | View |
| None | Interferon Alpha-2b | View |
| None | Thalidomide | View |
| None | Thalomid | View |
| None | Temodar | View |
| None | Proleukin | View |